Treatment of hyperproliferative diseases

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 31/10 (2006.01) A61K 31/11 (2006.01) A61K 31/145 (2006.01) A61K 31/225 (2006.01) A61K 31/285 (2006.01) A61K 31/415 (2006.01) A61K 31/575 (2006.01) A61K 31/7088 (2006.01) A61K 38/17 (2006.01) A61P 17/00 (2006.01) A61P 35/00 (2006.01) C07K 16/28 (2006.01) G01N 33/50 (2006.01) G01N 33/566 (2006.01)

Patent

CA 2419840

We describe methods and compositions for treating a patient suffering from a hyperproliferative disorder or photoageing. Our methods involve blocking the activity of a retinol binding protein receptor (RBPr) in cells of the patient, and/or administering to the patient an antagonist of a retinol binding protein receptor (RBPr) and/or lowering the endogenous level of retinoic acid (RA) in cells of said patient.

L'invention concerne un procédé et des compositions permettant de traiter un patient souffrant d'un trouble d'hyperprolifération ou de photovieillissement. Ce procédé consiste à bloquer l'activité d'un récepteur de protéine de liaison du rétinol (RBPr) dans les cellules du patient, et/ou administrer au patient un antagoniste d'un récepteur de protéine de liaison du rétinol (RBPr) et/ou abaisser le niveau endogène d'acide rétinoïque (RA) dans les cellules dudit patient.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of hyperproliferative diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of hyperproliferative diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of hyperproliferative diseases will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1731658

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.